Palliative radiotherapy aims at a fast rate of regression and a maximum delay in growth with radiation doses of subtolerance level; while radical radiotherapy aims at maximum local tumour control with radiation doses of tolerance level. These aims point to the importance of exploring the rate and the pattern of tumour regression, the delay in growth of recurrent tumours and the probability of local tumour control.
Regression of both human and animal tumours following irradiation has always interested radiotherapists and radiobiologists for the following reasons: (I) Tumour regression is associated with symptomatic and psychological relief of the patient, and hence, rapid tumour regression is the goal of every radiotherapist.
(2) A process of reoxygenation can be expected as the tumour shrinks rapidly following irradiation, with reduction of the number of hypoxic cells after the first dose, leading to a more effective second dose and fractionated irradiation (Howes 1969 , Suit & Maeda 1967 , Fowler et al. 1975 , Kallman 1972 , Fowler et al. 1974 (3) The rate and pattern of regression might be an early indicator of the outcome of the treatment and any further necessary therapy.
In the present study, the gross response of a murine tumour, following single doses of irradiation, has been analysed during regression and recurrence in an attempt to find out its influence on the outcome of the treatment with single doses of X-ray alone and after minimizing the effect of hypoxic cells in the tumour with the hypoxic cell radiosensitizer misonidazole (Adams 1973 , Fowler et al. 1976 ).
Materials and methods
The tumour used in this study was a fast-growing, multiple-generation C 3H mammary tumour, maintained at our laboratory by subcutaneous transplantation of a cytosieve tumour cell suspension every two to three weeks in the dorsum of eight-to twelve-weeks-old C 3H inbred mice of either sex. The tumour grew readily, forming fairly round, freely movable tumours, which were selected for irradiation when they reached a mean diameter of between 5.0 and 7.0 mm, at which time they had a volume-doubling time of just over one day.
The X-irradiations were performed using a Siemens Stabilipan machine at 250 kV, halfvalue layer 1.85 ±0.05 mm Cu with a dose rate of l.l Gyjminute at 57 cm focus-to-skin distance. All the irradiation procedures were carried out at room temperature, with mice breathing air and without anaesthesia, in specially designed cylindrical jigs made of lead 2 mm thick to shield all the body of the mouse except the tumour. Extra lead sheets were used to limit the width of the field of irradiation to 1.5 em, across which four tumours could be irradiated simultaneously in a tangential position.
In order to measure the gross response of the tumours to irradiation, the size of each tumour was measured three to five times per week over three mutually perpendicular diameters. The geometric mean diameter was calculated for each individual tumour each day. To obtain the actual diameter of the tumour mass, 1.25 mm average double skin thickness was then subtracted. The tumour model was suitable for this study due to the apparent rarity of metastases. From a total of 293 mice bearing tumours, irradiated with single doses of 50 Gy or more and split doses of total 70 Gy, only 10mice (3.4%) died unexpectedly or were killed due to sickness and not due to the primary tumour. Post-mortem examination of 4 of these mice revealed no gross metastases (see Walker et al., 1978) .
The sensitizer drug misonidazole was freshly made up as a sterile solution in 0.9% weight-byvolume saline and was injected intraperitoneally (1 mg/g body weight) 30 minutes before the start of irradiation. A period of 100 days after irradiation was chosen as the most suitable for the end point of the tumour control experiments. Tumours that regressed completely and remained so during this period were considered to be locally controlled (cured). Figure I shows the gross response of the tumour to various single doses of X-rays of 5-80 Gy. The mean diameter minus the skin thickness is plotted against the post-irradiation period in days. There was no significant difference in the growth of irradiated tumours from that of the control group for about two days. Thereafter a clear dependence of tumour growth on dose level can be seen and this becomes more evident with time. There is a progressive flattening of the early part of the growth curves, which is more obvious as the dose increases toward 40 Gy, when the early part of the growth curve follows the same pattern as those of doses of 50 Gy or more for about twelve days before regrowth. Tumour regression is only evident after single doses of 50 Gy or more. There is then a similar pattern of regression following both a noncurative dose, such as 50 Gy and a curative dose, such as 80 Gy. Figure 2 shows the effect of misonidazole on the gross response of the tumour to irradiation. The response is similar to that seen in Figure I , but with lower dose levels. A similar pattern of regression can also be seen with doses from 25 Gy up to 50 Gy.
Results
The characteristic rate and pattern of regression of this tumour after irradiation can be seen in Figure 3 . This shows the average regression patterns after single doses of 60 Gy or more of X-rays alone and with single doses of 25 Gy or more in combination with misonidazole. The tumours continue to increase in size for about two days, then return slowly to the preirradiation size about twelve days after irradiation. This is followed by a relatively faster regression towards a minimal size in about twenty days from the day of irradiation. Post-irradiation period (days)
25Gy-50Gy +Mlsonidazole The incidence of complete regression and the local tumour control probability for X-rays alone are shown in Table I . It is clear that the incidence of complete regression is dose dependent. None of the tumours which were exposed to 50 Gy showed complete regression. Thereafter the incidence of complete regression increased with dose, reaching 100% at the 100% curative dose of 80 Gy. These data are shown in Figure 4 , where the local control probability is plotted as a function of the incidence of complete regression at each dose level. There appears to be a significant correlation with single doses above 60 Gy. The latter dose produced 55% complete regression but only 11 % local control. Figure 5 shows the range of times for noncured tumours to regrow to 10 mm mean diameter from the size at irradiation, for different doses of X-rays alone and X-rays in combination with misonidazole. The comparison between the two curves demonstrates clearly the existence of the radioresistant hypoxic cells in the tumours. There is a similarity in pattern between these curves and those published for many other animal tumours of different histology and rate of growth. Each curve has a steeper part over which maximum delay in growth occurs with increase in dose. The steeper part originates at 50 Gy for X-rays alone and at lOGy for X-rays in combination with misonidazole.
Discussion
Despite the fact that the results of animal experiments are not directly applicable to human tumours, the information obtained from these experiments has proved very useful in our understanding of radiotherapy. The observed gross response of tumours after irradiation is the net result of many dynamic processes: mainly cell death, cell loss and cell production. Both Suit et al. (1965) and Denekamp (1977) commented that the observed response of tumours after irradiation would reflect the rate of removal of the dead cells and cell debris and the efficiency of cell loss mechanisms. Thomlinson (1970) pointed out that these mechanisms can be affected by radiation.
The pattern of shrinkage and the time required for the tumour mass to regress completely after large doses of radiation vary in tumours with different histological structure and rate of growth. Furthermore, the regression rates tend to be similar within each tumour type over the range of large doses. These observations can be deduced from the several published gross response curves for a variety of animal tumours following irradiation (Thomlinson & Craddock 1967 , Barendsen & Broerse 1970 , Hill & Fowler 1977 , Sheldon & Hill 1977 . This is also the case in our tumour system, where a characteristic pattern and rate of regression after Irradiation exist, even at a relatively low single dose of 25 Gy as revealed by misonidazole. The magnitude of cell killing with doses less than 20 Gy is not enough to show if this pattern still exists at such lower doses. This is of interest, since the tumour bed effect seems to plateau at doses of 20 Gy or more (Hewitt & Blake 1968 , Summers et al. 1964 . Below this dose level damage to the tumour vasculature, lymphatics and the cell loss mechanisms would be less and hence a faster rate of regression may occur.
The similar pattern of regression that emerges following both noncurative and curative doses for both X-rays alone and in combination with misonidazole, strongly suggests that once the tumour has been depopulated to a low level or all the cells have been killed, the pattern and the rate of regression would be similar. This would be the result only of the rate of removal of the doomed tumour cells and cell debris, and the efficiency of the mechanisms responsible for that.
The rate and pattern of regression following irradiation appear to be a characteristic feature for each type of tumour and one cannot expect a faster rate of regression, however high a dose is given. This would be so whether or not all the tumour cells are rendered sensitive to radiation killing by oxygen or hypoxic cell radiosensitizers, Other modalities of treatment such as chemotherapy or hyperthermia may produce a different response. The presence of hypoxic cells in the tumours can be assumed to explain the difference in the observed gross response between tumours irradiated with X-rays alone and those irradiated in combination with misonidazole ( Figures I, 2) after the same dose of radiation. This may explain the observed heterogeneity in response to similar doses of radiation between tumours of the same types; both human and animal. If this is the case, the characteristic pattern of regression of the tumour type will be revealed either by an increase in dose or radiosensitization of the cells by oxygen or hypoxic cell radiosensitizers.
The process of reoxygenation occurs early as the tumour shrinks following irradiation. The reduction of intercapillary distances and the relief of compression on the tumour capillaries improve the oxygenation status of the remaining cells, especially with the availability of more oxygen for consumption after the metabolic inhibition and killing of many tumour cells. Fowler et al. (1974 Fowler et al. ( , 1975 showed that reoxygenation was the most important factor in determining the response of first generation C 3H mammary tumour, which regressed in two to three days after a single dose of 15 Gy (Howes 1969) . In our tumour system regression became evident twelve days from the day of irradiation. Single doses below 50 Gy in the absence of misonidazole did not produce any regression. This may mean that reoxygenation is not and will not be an important factor in our tumour system and other means designed to overcome radioresistant hypoxic cells should be used in this tumour and similar slowly regressing tumours, where the beneficial effect of reoxygenation with fractionated irradiation is not expected.
There has been much controversy about the existence of a relationship between tumour regression and local control in both human and animal tumours. The establishment of a consistent relationship would permit selection of optimum radiation doses and any further treatment necessary to achieve cure, if the outcome of the treatment is known in advance. Suit et al. (1965) did not find any prognostic significance of tumour regression after large single doses in spontaneous C 3H mammary tumours and in 72 patients with squamous cell carcinoma of the head and neck treated with conventional fractionated radiotherapy. Friedman et al. (1967) , in a study of 123 patients with Hodgkin's disease, found a mixed pattern of the rate of tumour shrinkage in half of these patients and concluded that the rate of shrinkage could not be used for clinical or radiobiological purposes. On the other hand, Marcial & Bosch (1970) and Grossman et al. (1973) , in studies of patients with carcinoma of the uterine cervix, concluded that complete tumour regression, early or late, is associated with excellent survival. Denekamp (1977) , in a retrospective analysis of the first generation C 3H mammary tumour, found a correlation between shrinkage and the ultimate cure probability after single or fractionated irradiation. Our data point to the careful analysis needed to find out any correlation between the gross response following irradiation and the local tumour control probability. All the tumours which showed minimal or incomplete regression, with persistent residual tumour mass, eventually recurred, irrespective of the dose. Furthermore, the observed tumour response during the regression period cannot predict the ultimate fate of the tumour due to the similar pattern of regression following both noncurative and curative doses for both X-rays alone and in combination with misonidazole. However, a significant correlation does exist in completely regressed tumours, but only after a dose level of 60 Gy which is threequarters of the 100% curative dose of 80 Gy in the case of X-rays alone. The data from the misonidazole experiments ale still under analysis and may show a different relationship after minimizing the effect of hypoxic tumour cells.
In the clinical experience of Ralston Paterson (1956) , low dosage is not very effective for palliation and some two-thirds to three-quarters of the dosage which would be employed for radical radiotherapy is usually needed to achieve consistent palliation. Several of the published growth delay curves of recurrent animal tumours of different histology and rate of growth (Thomlinson & Craddock 1967 , Field et al. 1967 , Denekamp & Harris 1968 , McNally & Sheldon 1977 , Hill & Fowler 1977 show that these curves have steeper parts over which increasing delay in growth can be achieved with increasing dose. If this pattern is also followed with human tumours, palliative doses should be chosen on the steeper parts of the curves. Unfortunately, no such curves exist for human tumours, due to the lack of enough clinical data for tumour recurrence or early death due to distant metastases. In our tumour system, palliative doses should be above 50 Gy which is two-thirds of the 100% curative dose, namely 80 Gy, in the case of X-rays alone. The use of misonidazole has lowered this dose to 10 Gy, which is only one-fourth of the 100% curative dose, i.e. 40 Gy with the drug. This might suggest that effective palliation can be achieved in well oxygenated tumours or by making use of other means such as radiosensitizers to overcome the problem of the resistant hypoxic tumour cells.
Summary
The gross response of a serially transplanted C 3H mammary tumour has been analysed following treatment with single doses of X-rays. A characteristic rate and pattern of tumour regression were revealed with either high doses of X-rays alone or the use ofmisonidazole plus relatively low doses of X-rays. The observed tumour response during the regression period could not predict the ultimate fate of the tumour; however, a significant correlation did exist in completely regressed tumours but only after a certain dose level. The doses needed to achieve an appreciable delay in growth were more than two-thirds of the 100% curative dose in the case of X-rays alone. The use of misonidazole has lowered this dose level to one-quarter of the curative dose. This study confirms the effects of hypoxia in tumours and the need to overcome this problem.
.
